1. Home
  2. TSLX vs VCEL Comparison

TSLX vs VCEL Comparison

Compare TSLX & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$18.32

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$33.34

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
VCEL
Founded
2010
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
TSLX
VCEL
Price
$18.32
$33.34
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$22.13
$58.50
AVG Volume (30 Days)
1.6M
423.1K
Earning Date
05-14-2026
05-18-2026
Dividend Yield
11.18%
N/A
EPS Growth
N/A
60.00
EPS
1.81
0.32
Revenue
N/A
$276,259,000.00
Revenue This Year
N/A
$19.09
Revenue Next Year
$1.92
$17.96
P/E Ratio
$10.13
$105.00
Revenue Growth
N/A
16.45
52 Week Low
$16.99
$29.24
52 Week High
$25.17
$49.10

Technical Indicators

Market Signals
Indicator
TSLX
VCEL
Relative Strength Index (RSI) 39.19 37.46
Support Level N/A $29.59
Resistance Level $22.46 $38.48
Average True Range (ATR) 0.62 1.57
MACD 0.08 -0.34
Stochastic Oscillator 55.28 10.53

Price Performance

Historical Comparison
TSLX
VCEL

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: